Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer? ; volume:13 ; number:1 ; day:20 ; month:3 ; year:2018 ; pages:1-9 ; date:12.2018
Diagnostic pathology ; 13, Heft 1 (20.3.2018), 1-9, 12.2018
- Creator
-
Eriksen, Ann C.
- Contributor
-
Andersen, Johnnie B.
Lindebjerg, Jan
dePont Christensen, René
Hansen, Torben F.
Kjær-Frifeldt, Sanne
Sørensen, Flemming B.
SpringerLink (Online service)
- DOI
-
10.1186/s13000-018-0697-9
- URN
-
urn:nbn:de:1111-2018052026811
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eriksen, Ann C.
- Andersen, Johnnie B.
- Lindebjerg, Jan
- dePont Christensen, René
- Hansen, Torben F.
- Kjær-Frifeldt, Sanne
- Sørensen, Flemming B.
- SpringerLink (Online service)
Other Objects (12)
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Bioinformatics pipeline for revealing tumour heterogeneity: Bioinformatics pipeline for revealing tumour heterogeneity from single cells
Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
Histone variants: critical determinants in tumour heterogeneity
Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
The role of integrins in TGFβ activation in the tumour stroma
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Bioinformatics pipeline for revealing tumour heterogeneity: Bioinformatics pipeline for revealing tumour heterogeneity from single cells
Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
Histone variants: critical determinants in tumour heterogeneity
Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
The role of integrins in TGFβ activation in the tumour stroma
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Bioinformatics pipeline for revealing tumour heterogeneity: Bioinformatics pipeline for revealing tumour heterogeneity from single cells
Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
Histone variants: critical determinants in tumour heterogeneity
Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
The role of integrins in TGFβ activation in the tumour stroma
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes